Considering that BCL6 is widely involved in the progression of NAFLD as well as the fact that fatty liver previously demonstrates markedly reduced BCL6 expression, we speculate that aberrant BCL6 expression may have an important influence on NAFLD. The gene discussed is BCL6; the disease is Hepatic steatosis.